0
Research
Improved antiretroviral refill adherence in HIV-focused community pharmacies
Jennifer M. Cocohoba; Patricia Murphy; Glen Pietrandoni; B. Joseph Guglielmo
J Am Pharm Assoc (2003) 2012;52:e67-e73. doi:10.1331/JAPhA.2012.11112

Abstract

Objective  To determine differences in patient characteristics, antiretroviral therapy (ART) regimen characteristics, and regimen refill adherence for human immunodeficiency virus (HIV)-focused pharmacy (HIV-P) versus traditional pharmacy (TP) users.

Design  Retrospective cohort study.

Setting  California Walgreens pharmacies from May 2007 to August 2009.

Participants  HIV-positive patients with greater than 30 days of antiretroviral prescription claims.

Intervention  Deidentified prescription records for patients filling any ART prescription at any California Walgreens pharmacy during the study period were assessed.

Main outcome measures  ART regimen refill adherence (calculated by modified medication possession ratio [mMPR]) and dichotomous measure of optimal adherence of 95% or greater.

Results  4,254 HIV-P and 11,679 TP users were included. Compared with TP users, HIV-P users traveled farther to pharmacies (5.03 vs. 1.26 miles, P < 0.01). A greater proportion of HIV-P users filled prescriptions for chronic diseases (35% vs. 30%) and received fixed-dose combination antiretroviral tablets (92% vs. 83%) (all P < 0.01). Median mMPR was higher for HIV-P users (90% vs. 77%, P < 0.0001). After adjusting for age, gender, insurance, medication use, and distance from pharmacy, use of HIV-P (odds ratio 1.90 [95% CI 1.72–2.08]) and fixed-dose combination antiretroviral tablets (3.34 [2.84–3.96]) were most strongly associated with having 95% or greater ART regimen refill adherence.

Conclusion  For HIV-positive patients struggling with antiretroviral adherence, clinicians may consider minimizing pill burden with combination tablets and referral to an HIV-focused pharmacy.

Sign In
APhA Members 
Welcome to JAPhA.org! Please log in below using your APhA username and password. Update your APhA profile.
Not a Subscriber
New to JAPhA? Become an APhA member to receive a full subscription to both the print and online editions.

OR

Register for a FREE limited account to benefit from personalization features such as alerts.

References

Press N, Tyndall MW, Wood E, et al.  Virologic and immunologic response, clinical progression, and highly active antiretroviral therapy adherence.  J Acquir Immune Defic Syndr.  2002; 31( suppl 3): S112– 7. [PubMed]
 
Paterson DL, Swindells S, Mohr J, et al.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.  Ann Intern Med.  2000; 133: 21– 30. [PubMed]
 
Miller LG, Liu H, Hays RD, et al.  Knowledge of antiretroviral regimen dosing and adherence: a longitudinal study.  Clin Infect Dis.  2003; 36: 514– 8. [PubMed]
 
Jodlowski TZ, Sym D, Conry J, et al.  Antiretroviral medication knowledge among New York State pharmacists: room for improvement.  J Pharm Pract.   2010; 23: 507– 10. [PubMed]
 
Racey CS, Zhang W, Brandson EK, et al.  HIV antiviral drug resistance: patient comprehension.  AIDS Care.  2010; 22: 816– 26. [PubMed]
 
Cocohoba J, Dong B.  ARV medication errors: experience of a community based HIV specialty clinic and review of the literature.  Hosp Pharm.  2007; 42: 720– 8.
 
Edelstein H, Wilson M.  Antiretroviral medication errors were universal in hospitalized HIV-seropositive patients at a teaching hospital.  J Acquir Immune Defic Syndr.  2001; 28: 496. [PubMed]
 
Purdy BD, Raymond AM, Lesar TS.  Antiretroviral prescribing errors in hospitalized patients.  Ann Pharmacother.  2000; 34: 833– 8. [PubMed]
 
Robinson CA, Cocohoba J, MacDougall C, et al.  Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients.  J Am Pharm Assoc.  2007; 47: 613– 5.
 
Hirsch JD, Gonzales M, Rosenquist A, et al.  Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.  J Manag Care Pharm.  2011; 17: 213– 23. [PubMed]
 
Hirsch JD, Rosenquist A, Best BM, et al.  Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.  J Manag Care Pharm.  2009; 15: 32– 41. [PubMed]
 
Rosenquist A, Best BM, Miller TA, et al.  Medication therapy management services in community pharmacy: a pilot programme in HIV specialty pharmacies.  J Eval Clin Pract.  2010; 16: 1142– 6. [PubMed]
 
Inciardi JF, Leeds AL.  Assessing the utility of a community pharmacy refill record as a measure of adherence and viral load response in patients infected with human immunodeficiency virus.  Pharmacotherapy.  2005; 25: 790– 6. [PubMed]
 
Fairley CK, Permana A, Read TR.  Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.  HIV Med.  2005; 6: 366– 9. [PubMed]
 
Gross R, Yip B, Re V 3rd Lo, et al.  A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression.  J Infect Dis.  2006; 194: 1108– 14. [PubMed]
 
Grossberg R, Gross R.  Use of pharmacy refill data as a measure of antiretroviral adherence. Curr HIV/AIDS Rep.  2007; 4( 4): 187– 91.
 
Grossberg R, Zhang Y, Gross R.  A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV.  J Clin Epidemiol.  2004; 57: 1107– 10. [PubMed]
 
Bisson GP, Gross R, Bellamy S, et al.  Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.  PLoS Med.  2008; 5( 5): 109.
 
Department of Health & Human Services Public Service Task Force.  Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Accessed at www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf,  January 6, 2012.
 
Women's Interagency HIV Study.  Definition of highly active antiretroviral therapy (HAART). Accessed at https://statepiaps.jhsph.edu/wihs/Invest-info/Def-HAART_0609.pdf,  January 6, 2012.
 
Multicenter AIDS Cohort Study.  HAART definition. Accessed at www.statepi.jhsph.edu/macs/manuscript.html,  January 6, 2012.
 
Bangsberg DR.  Less than 95% adherence to nonnucleoside reverse-transcriptase inhibitor therapy can lead to viral suppression.  Clin Infect Dis.  2006; 43: 939– 41. [PubMed]
 
Bangsberg DR, Acosta EP, Gupta R, et al.  Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness.  AIDS.  2006; 20: 223– 31. [PubMed]
 
Bangsberg DR, Hecht FM, Charlebois ED, et al.  Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.  AIDS.  2000; 14: 357– 66. [PubMed]
 
Bangsberg DR, Porco TC, Kagay C, et al.  Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates.  J Infect Dis.  2004; 190: 162– 5. [PubMed]
 
Kuhn C, Powell PH, Sterrett JJ.  Elective course on medication therapy management services.  Am J Pharm Educ.  2010; 74( 3): 40. [PubMed]
 
Blake KB, Madhavan SS, Scott VG, et al.  Medication therapy management services in West Virginia: pharmacists’ perceptions of educational and training needs.  Res Social Adm Pharm.  2009; 5: 182– 8. [PubMed]
 
Bunting BA, Cranor CW.  The Asheville Project: long-term clinical, humanistic, and economic outcomes of a community-based medication therapy management program for asthma.  J Am Pharm Assoc.  2006; 46: 133– 47.
 
Bunting BA, Smith BH, Sutherland SE.  The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.  J Am Pharm Assoc.  2008; 48: 23– 31.
 
Cranor CW, Bunting BA, Christensen DB.  The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program.  J Am Pharm Assoc.  2003; 43: 173– 84.
 
Barnett MJ, Frank J, Wehring H, et al.  Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.  J Manag Care Pharm.  2009; 15: 18– 31. [PubMed]
 
Llibre JM, Arribas JR, Domingo P, et al.  Clinical implications of fixed-dose coformulations of antiretrovirals on the outcome of HIV-1 therapy.  AIDS.  2011; 25: 1683– 90. [PubMed]
 
Stone VE, Jordan J, Tolson J, et al.  Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence.  J Acquir Immune Defic Syndr.  2004; 36: 808– 16. [PubMed]
 
Steiner JF, Prochazka AV.  The assessment of refill compliance using pharmacy records: methods, validity, and applications.  J Clin Epidemiol.  1997; 50: 105– 16. [PubMed]
 
Andrade SE, Kahler KH, Frech F, et al.  Methods for evaluation of medication adherence and persistence using automated databases.  Pharmacoepidemiol Drug Saf.  2006; 15: 565– 74. [PubMed]
 
Hess LM, Raebel MA, Conner DA, et al.  Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures.  Ann Pharmacother.  2006; 40: 1280– 8. [PubMed]
 
McMahon JH, Jordan MR, Kelley K, et al.  Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring.  Clin Infect Dis. 52: 493– 506. [PubMed]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).
Please read the other comments before you post yours. Comments are moderated and will appear on the site at the discertion of the editorial staff.
* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content

Customize your page view by dragging & repositioning the boxes below.

JAPhA Articles
Topic Collections
PubMed Articles
Advertisement
 
  • Print
  • PDF Download
  • Email
  • Share
  • Get Citation
  • Submit Comment
  • Article Alerts
    Please Wait... Processing your request... Please Wait.
    You must sign in to sign-up for alerts.

    Please confirm that your email address is correct, so you can successfully receive this alert.

  • Letters To Editor
  • Reprints